1.
Clin Case Rep
; 8(5): 877-882, 2020 May.
Article
in English
| MEDLINE
| ID: mdl-32477538
ABSTRACT
Atypical chronic lymphocytic lymphoma (CLL) with CCND1 translocation is poorly described, particularly in the era of modern inhibitors of the B-cell receptor pathway. We present a patient with atypical CLL who had a significant response to ibrutinib, highlighting the effectiveness of this agent in higher risk CLL subgroups.
2.
BMJ Case Rep
; 13(4)2020 Apr 06.
Article
in English
| MEDLINE
| ID: mdl-32265213